-
Rambam Launches a New Multidisciplinary Ambulatory Internal Medicine Ward
October 26, 2025 – Rambam Health Care Campus (Rambam) recently inaugurated a new multidisciplinary Internal Medicine Day Hospitalization Center, featuring 14 treatment stations and offering advanced medical services across multiple specialties. Rambam’s recently opened Internal Medicine Day Hospitalization Center provides ambulatory treatments for patients not requiring in-patient hospitalization from the Department of Neurology, the Pain Management Institute, and the Liver Unit. Comprised of 14 treatment stations, it will also serve gastroenterology patients receiving advanced biological…
-
Azrieli Family is Honored by Rambam’s Leadership at Groundbreaking Ceremony for State-of-the-Art Pediatric Rehabilitation Center
October 22, 2025 – The Azrieli Foundation was honored by Rambam at a moving groundbreaking ceremony for the new Azrieli Foundation Pediatric Rehabilitation Center. In recognition of their extraordinary philanthropy and many contributions to Israel and to Rambam. Danna, Naomi and Sharon Azrieli also received the prestigious Rambam Award. Rambam Health Care Campus welcomed Danna, Naomi and Sharon Azrieli and members of the Board of Directors of Azrieli Foundation Canada (AFC) and Azrieli Foundation Israel (AFI),…
-
Rambam Expert Weighs in on Nobel Prize in Medicine
October 20, 2025 – The 2025 Nobel Prize in Medicine was awarded to Professor Shimon Sakaguchi, Professor Mary E. Brunkow, and Dr. Fred Ramsdell for their groundbreaking discoveries about regulatory T cells and the concept of immune tolerance. Their work has reshaped our understanding of how the immune system maintains balance—defending against threats while avoiding attacks on the body itself. Dr. Idit Lahover-Rot, director of the Allergy and Clinical Immunology Unit at Rambam Health Care Campus, is an expert in understanding how the immune…
-
Rambam Mourns, Rambam Remembers
October 16, 2025 – On Black Saturday, October 7, 2023 — Israel’s longest war in history, the Swords of Iron War, began. This morning, hundreds gathered at Rambam Health Care Campus (Rambam) to remember, commemorate, and mourn the events of the past two years. The ceremony opened with the lowering of the Israeli flag to half-mast. Professor Michael Halberthal, Rambam’s director general — concluding his term at the end of October — spoke of the…
-
Canned Tuna and Mercury Exposure: What You Need to Know
September 29, 2025 – Concerns about high mercury levels in canned tuna, a popular choice on many tables, have reignited. What are the dangers, and who is most vulnerable? Canned tuna is a readily available and affordable source of protein; however, excessive consumption can be detrimental. Investigations by environmental organizations Bloom and Food Guardians in 2022 and 2024 revealed widespread mercury contamination in tuna, the most commonly consumed fish in Europe. Tests on 148 cans purchased across five European…
-
Rambam Summit 2025: Celebrating Growth, Vision, Resilience, Courage, and Hope
September 17, 2025 – Between sorrow and joy, remembrance and vision, the 2025 Rambam Summit unfolded as a tapestry of emotion and meaning—affirming Rambam Health Care Campus (Rambam) as a beacon of healing, a pillar of resilience, and an inseparable part of Israel’s story. Since its inception in 2010, the annual Rambam Summit has celebrated the intertwining of medicine, technology, and humanity. Each Summit has been a joyful recap of the past year’s achievements and…
-
Rambam Builds Bridges to India’s Healthtech Future: Strategic Partnerships with AIG Hospitals and Bharat Biodesign
September 15, 2025 – Rambam Health Care Campus (Rambam) has signed two new memoranda of understanding, forging alliances with AIG Hospitals and Bharat Biodesign to drive joint medical innovation and healthtech collaboration. Last week, Dr. Yona Vaisbuch, a senior physician at Rambam’s Department of Otolaryngology-Head & Neck Surgery and founding director of Biodesign Israel, returned from India after participating in the International Biodesign Conference. While there, he held a series of meetings that led to…
-
Rebuilding Faces, Restoring Lives: The Remarkable Impact of the Oral and Maxillofacial Surgery Department
September 3, 2025: What an extraordinary evening we shared with Rambam’s rising star, Dr. Adi Katz Biton! Guests were deeply moved and inspired by her dedication, talent, and charisma. Our gracious hosts, Robin and Boris Feldman, helped create this special evening in Palo Alto possible by opening their home and hearts. Dr. Biton and her team’s groundbreaking world-class expertise – rebuilding the faces and restoring the lives of severely wounded IDF soldiers – is nothing short of…
-
Fatty Liver: Confronting a Silent Disease
September 8, 2025 – Fatty liver disease has become increasingly common, affecting roughly one-third of the population. If left undiagnosed, it can quietly progress to cirrhosis and even cancer. What are the risk factors, and how is it diagnosed and treated? Fatty liver disease—also known as hepatic steatosis or steatotic liver disease—is a condition in which excess fat accumulates in the liver. Although early stages often present few or no symptoms, the disease can become…
-
Rambam Oncologist Leads Global Guidelines for Lung Cancer Treatment
September 4, 2025 – It’s not every day that physicians receive international recognition for their contributions to healthcare. But when a physician from Rambam Health Care Campus (Rambam) is honored in this way, it not only affirms their professional excellence—it reflects their deep commitment to Rambam’s mission. Every five years, clinical guidelines for the treatment of lung cancer are revised. This year, Professor Alona Zer Kuch, director of Medical Oncology at the Joseph Fishman Oncology…
-
When Dry Eyes Become a Problem: Insight from a Rambam Expert
September 1, 2025 – It may feel like just a little irritation, but untreated dry eye syndrome can cause lasting damage. Millions worldwide suffer from it without realizing, and Rambam experts warn the risk only increases with age. Dry eye syndrome isn’t just “having dry eyes.” It’s a chronic condition in which the eyes do not produce enough tears, or the tears evaporate too quickly. Beyond discomfort, it can blur vision, damage the cornea, and…
-
First in Israel: Gene-Editing Therapy for Heart Failure
August 26, 2025 – For the first time in Israel, Rambam Health Care Campus (Rambam) is testing a revolutionary gene-editing treatment that could halt a deadly form of heart failure. The same technology may soon target another global killer: high cholesterol. In collaboration with Intellia Therapeutics, a U.S. biotech company, Rambam is conducting the first gene-editing clinical trial of its kind in Israel to treat transthyretin amyloidosis. The condition is sometimes hereditary, but more often…
